However, LPAR1 expression has also been reported to be significantly increased in other tumors, such as human hepatic cancer [29], osteosarcoma [30] and ovarian cancer [31], and to exert tumor-promoting effects directly or mediated by chemotherapy resistance [30,32]. Here, LPAR1 is linked to neoplasm.